Finally, examining The Cancer Genome Atlas or TCGA, PDGF-D was observed in multiple human tumors and the presence of NCR2- activated gene expression “signatures” correlated with superior outcome in glioblastoma but not other cancers [1]. The gene discussed is NCR2; the disease is glioblastoma.